Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Endocrine 2Plasma cell 1Other hematologic neoplasm 1Myeloid 1Lymphoid 1

Conditions

Pituitary Neoplasms 2Dwarfism, Pituitary 2Pituitary Diseases 1Metabolic Syndrome 1Hypopituitarism 1Atherosclerosis 1

Interventions

lutetium Lu 177 dotatate 36Everolimus 32pembrolizumab 24Temozolomide 21Magnetic Resonance Spectroscopy 21Nivolumab 18lenvatinib 17gallium Ga 68 dotatate 16cabozantinib 15Cisplatin 15lanreotide 143-Iodobenzylguanidine 14Capecitabine 13trametinib 12dabrafenib 12Bevacizumab 12Octreotide 11Surveys and Questionnaires 10Surgical Procedures, Operative 10Sunitinib 10Radiosurgery 10Positron Emission Tomography Computed Tomography 10Blood Specimen Collection 10Sorafenib 9Paclitaxel 9Ipilimumab 9Carboplatin 9surufatinib 8Etoposide 8Doxorubicin 8

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Human Growth Hormone × Endocrine × Clear all
NCT00136032 2008-02-18

Growth Hormone Administration and Its Effects on Cardiovascular Risk Factors in Growth Hormone Deficient Women

Massachusetts General Hospital

Phase NA Completed
63 enrolled
Endocrine

Dwarfism, Pituitary, Pituitary Diseases, Pituitary Neoplasms

NCT00462475 2007-10-16

5yrGH

Federico II University

Completed
20 enrolled
Endocrine

Dwarfism, Pituitary, Hypopituitarism, Pituitary Neoplasms, Metabolic Syndrome, Atherosclerosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡